Advancing Autonomous AI for Clinical Decision-Making in Oncology - The Babak Lab / artificial intelligence, cancer, Daniel Truhn, Dirk Jäger, Dyke Ferber,

Anti-amyloid monoclonal antibodies are transforming Alzheimer's care, but clinicians now face a new challenge: which patients should continue therap… #Alzheimersdisease #AmyloidPETimaging #Clinicaldecisionmaking #Donanemab #Lecanemab

Background Recent breakthroughs in artificial intelligence research include the development of generative pretrained transformers (GPT). ChatGPT has been shown to perform well when answering several s...

Anti-amyloid monoclonal antibodies are transforming Alzheimer's care, but clinicians now face a new challenge: which patients should continue therap… #Alzheimersdisease #AmyloidPETimaging #Clinicaldecisionmaking #Donanemab #Lecanemab

"Do no harm" is winning. That should worry us" A 2026 survey of 227 primary and urgent care clinicians asked whether the four principles of bioethics are genuinely equal. Just over half (51.9%) said...

Artificial intelligence (AI) is increasingly integrated into clinical decision-making, but strategies for human–AI collaboration remain underdeveloped. A recent randomized trial by Qazi and colleag...

Welcome to the Critical Appraisal of Research Evidence - Tutorial About Tools and Methods This tutorial covers essential tools and methods used to critically appraise research evidence, ensuring you can effectively evaluate the quality and relevance of scientific studies. Learn about various appraisal tools like CONSORT, PRISMA, CASP, and more. Gain insights into their application in evidence-based medicine to enhance your clinical decision-making and research evaluation skills. #CriticalAppraisal #ResearchEvidence #EvidenceBasedMedicine #CONSORT #PRISMA #CASP #MedicalResearch #HealthcareEducation #ResearchMethods #ClinicalDecisionMaking #AppraisalTools #MedicalTutorial #ResearchEvaluation

He, Ying et al. develop an explainable deep learning framework that combines post-hoc explainable AI and expert domain knowledge for insulin titration in type 2 diabetes management. This framework improves clinical decision-making, especially for junior clinicians, and may facilitate broader clinical adoption of AI-assisted decision-making tools.

Sciqst is a computational tool for life sciences. It creates scientific reviews from recent scholarly papers on your chosen topic.

Roche and Klinrisk have picked up a CE-mark for an AI tool that can be used to predict renal function decline in patients with chronic kidney disease.

OpenEvidence has raised $210m to expand the capabilities of its physician decision-making tool and launch a new service offering 'PhD-level' research.